Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Debt / NOTE 1.500%10/1
-
Market price (% of par)
-
111.49%
-
Total 13F principal
-
$313,848,215
-
Principal change
-
+$3,812,201
-
Total reported market value
-
$349,728,786
-
Number of holders
-
36
-
Value change
-
+$2,820,486
-
Number of buys
-
17
-
Number of sells
-
20
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q4 2018
As of 31 Dec 2018,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 was held by
36 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$313,848,215
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management GmbH, CALAMOS ADVISORS LLC, Invesco Ltd., ROYAL BANK OF CANADA, FRANKLIN RESOURCES INC, ADVENT CAPITAL MANAGEMENT /DE/, BANK OF AMERICA CORP /DE/, STATE STREET CORP, LORD, ABBETT & CO. LLC, and RWC Asset Management LLP.
This page lists
36
institutional bondholders reporting positions
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.